STEPHANIE DELVAUX: Open Payments
NPI 1871923201 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,340 in 68 payments from 15 companies in 2025. Trend: 2023 $1,423 · 2024 $1,707 · 2025 $1,340
Food & beverage: $1,340
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $483 |
| Madrigal Pharmaceuticals | 7 | $137 |
| PFIZER INC. | 6 | $122 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $109 |
| GENZYME CORPORATION | 4 | $99 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $82 |
| VIVUS LLC | 3 | $61 |
| Aimmune Therapeutics, Inc. | 3 | $55 |
| Intercept Pharmaceuticals, Inc. | 2 | $35 |
| Amgen Inc. | 2 | $34 |
Products named: RINVOQ, REZDIFFRA, DUPIXENT, XELJANZ, CREON, LINZESS, XIFAXAN, ENTYVIO.
Industry payments across FL — which companies pay providers there.
